
Join to View Full Profile
11970 N Central ExpySte 550Dallas, TX 75243
Phone+1 972-940-9520
Fax+1 972-940-9535
Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Washington School of MedicineFellowship, Advanced Heart Failure and Transplant Cardiology, 2018 - 2019
- University of WashingtonFellowship, Cardiovascular Disease, 2015 - 2018
- Emory University School of MedicineChief Residency, Internal Medicine, 2014 - 2015
- Emory University School of MedicineResidency, Internal Medicine, 2011 - 2014
- Geisel School of Medicine at DartmouthClass of 2011
- Grinnell CollegeBA, Biochemistry, 2003 - 2007
Certifications & Licensure
- TX State Medical License 2023 - 2026
- WA State Medical License 2015 - 2025
- ID State Medical License 2022 - 2024
- GA State Medical License 2014 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Phi Beta Kappa Honor Society 2007
- Mortar Board Honor Society 2006
Publications & Presentations
PubMed
- Reply: Optimizing Care During the "Golden Day of Shock".Van-Khue Ton, Song Li, Navin K Kapur
Journal of the American College of Cardiology. 2025-04-08 - Percutaneous Assessment and Intervention of Outflow Graft Stenosis in Left Ventricular Assist Device Patients-A Cohort Study.Claudio A Bravo, Fanette Chassagne, Alberto Aliseda, Jennifer A Beckman, Song Li
ASAIO Journal. 2025-03-25 - 1 citationsPractice Variation in Temporary Mechanical Circulatory Support for Cardiogenic Shock.Song Li, Arjun Bahl, Boyangzi K Li, Manreet K Kanwar, Borui Li
Journal of Cardiac Failure. 2024-12-12
Journal Articles
- Heterosubtypic Influenza Protection Elicited by Double-Layered Polypeptide Nanoparticles in MiceSong Li, MD, Proceedings of the National Academy of Sciences
Books/Book Chapters
Press Mentions
- Science News | Research: Innovative Cancer Chemoimmunotherapy Provided by Novel NanoparticlesNovember 25th, 2022
- Study Sifts Potential Factors of Device-Implant ComplicationOctober 31st, 2022
Grant Support
- Targeting iRhom to Improve Colon Cancer ImmunochemotherapyUNIVERSITY OF PITTSBURGH AT PITTSBURGH2025–2029
- Nanoparticles-mediated combination therapy for breast cancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
- Combination Therapy for Pancreatic CancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
- Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Mechanopriming for cell engineeringUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Multimodal wireless electrical stimulation for tissue regenerationUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
- Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Regulation of cell reprogramming by matrix stiffnessUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
- Study of Interleukin 33 as a new immunotherapy of lung cancerHACKENSACK UNIVERSITY MEDICAL CENTER2019–2025
- Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer ImmunotherapyUNIVERSITY OF CALIFORNIA LOS ANGELES2019–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: